← Timeline

CRWV · The Contracts Are Signed — Multi-Analyst Outlook 2026–2031

CRWV · Oct 23, 2026 · Analysis · Claude

⇆ Compare
CRWV$54.24▼ 62% off Oct ’25 high52-wk $53.50 – $141.79As of Oct 23, 2026

Independent analysis of CRWV — “CRWV · The Contracts Are Signed — Multi-Analyst Outlook 2026–2031”, published Oct 23, 2026 as part of Stock Timelines, a running journal of independent equity research. Featuring consensus target $130, projected target $144 (5y).

Key Research Takeaways: CRWV · The Contracts Are Signed — Multi-Analyst Outlook 2026–2031

Tickers Analyzed
CRWV
Consensus Price Target
$130
Projected Price Target (5y)
$144
Spot Price at Analysis
$54.24 (▼ 62% off Oct ’25 high)
52-Week Range
$53.5 - $141.79
Publication Date
Oct 23, 2026
Research Provider
Claude
01 · Equity deep-dive — synthesized analyst desk
CRWV
$54.24 ▼ 62% off Oct ’25 high
NASDAQ · NEOCLOUD / AI INFRASTRUCTUREMKT CAP ≈ $29.9B52-WK $53.50 – $141.79AS OF Oct 23, 2026 CLOSE

The contracts are signed. The capital is not.

CoreWeave has ~$104B of contracted backlog, revenue growing 112% and positive operating cash flow — yet the stock closed 1.4% above its 52-week low after a 36% slide from Sep 30. The market is pricing one question: can the money to energize that backlog be raised at a cost below what the contracts earn? Six analyst lenses, three scenarios, four horizons. At ~$75B of enterprise value the stock trades near 9.9× 2026E and 4.5× 2027E consensus adjusted EBITDA (derived).

The verdict · TL;DR
The core debate: is a $104B+ take-or-pay backlog an annuity that credit will eventually underwrite — or an obligation that must be financed near 15% before it ever becomes earnings? Bernstein sizes the outside funding need at ~$76B, Goldman at ~$19.5–23B. Probabilities are bear-tilted (30/45/25) because of 15% unsecured yields, a heavy funding need and ~24% short interest. The setup is a levered option, not a floor.
5-yr · prob-weighted
$159
+192% vs $54.24
52-week playback · where the tape sits❚❚ Pinned at the low
$54.24 · Oct 23, 2026consensus ≈$130 · +140%
$53.50 · 52-wk low · Oct 22, 2026$141.79 · 52-wk high · Oct 28, 2025
Price history + cone of outcomes · Mar 2025 → 2031
HISTORICALBULLBASEBEARPROB-WTDSTREET 12-MO
$10$20$40$80$160$320$640 Mar ’25Sep ’25Mar ’26Sep ’2620272028202920302031 $184 · Jun ’25 close peak $142 · 52-wk high $53.50 · 52-wk low · Oct 22 $68$83$116 $344 $144 $26 $159 TODAY · $54.24

Gray line = CoreWeave’s actual closes since its Mar 28, 2025 IPO, built only from dated anchor closes (Mar ’25 $37.08, Jun 20 ’25 $183.58, Oct 28 ’25 $139.93, Dec ’25 $71.61, Mar ’26 $77.47, Apr ’26 $111.60, Jun ’26 $99.54, Sep 30 $87.12, Oct 12 $80.26, Oct 14 $65.78, Oct 22 $55.60, Oct 23 $54.24); intra-period swings are not drawn. History and forecast panels use different px-per-month scales on a log price axis. Colored paths = synthesized scenario midpoints, probability-weighted (bear 30% · base 45% · bull 25%); open clay circle = Street 12-month consensus ≈$130 (range $39–$250). Scenario prices are illustrative frameworks, not forecasts.

Re-weight the scenarios

Those probabilities are a judgment call — so make them yours. Drag to set how likely the bear and bull cases are (base takes the remainder); the blended target below, the dotted line on the chart, and the prob-weighted row of the scenario cards all update live.

30% bear45% base25% bull
Blended 5-yr expected$159+192% vs $54.24
+112%
Q2’26 Revenue ($2.58B)
$104B
Revenue Backlog (+246%)
$1.51B
Adj. EBITDA (59% margin)
$128M
Adj. Operating Income (5%)
−$5.7B
Q2 Free Cash Flow
$640M
Q2 Net Interest Expense
−$626M
Q2 GAAP Net Loss
$35–39B
FY26 Capex Guide
02 · The panel — six ways to read the same tape

Six analyst lenses, six answers

Each lens is a synthesized expert perspective with its own 12-month target and the math behind it. Panel mean ≈ $74 vs. a Street consensus near $130 — the desk sits well below the sell-side.

Growth / Momentum PM

The Capacity Compounder

Backlog of $104B (+246%) plus >$25B of early-Q3 adds, 2026 revenue guided to $12.4–13.2B and consensus 2027 revenue near $26.5B. Prices were raised 25% in July and 10% in October. Operating leverage is appearing: adjusted operating income $128M vs $21M in Q1.

12-MO TARGET $119 · 6.0× NTM EBITDA $22B − $62B net debt, ~590M sh · conviction Medium
Value / FCF / Quality

The Credit Underwriter

TTM free cash flow is −$13.7B and net debt is ~$46B; there is no cash floor to underwrite. The equity is a levered option on contract conversion, so only a price that already discounts a 15% cost of capital is attractive.

12-MO TARGET $62 · 5.0× NTM EBITDA $21B − $66B net debt, ~630M sh · conviction Low
Bear / Short-seller

The Funding Gap

Bernstein-style math: ~$85B to fund the committed backlog, ~$9B covered, ~$76B outside. Interest is $640M a quarter and rising; short interest of 23.7% shows the debate is crowded but the credit tape agrees with the bears.

12-MO TARGET $39 · 4.5× NTM EBITDA $19B − $62B net debt, ~600M sh · conviction High
Moat / Competitive strategy

The Contract Book

Take-or-pay contracts with Microsoft, Meta, OpenAI and Anthropic are real moat-like visibility. But HSBC estimates ~$12M revenue per MW in 2027 vs $17–18M at hyperscalers, so the neocloud earns less per unit of power.

12-MO TARGET $92 · 6.0× NTM EBITDA $21B − $66B net debt, ~650M sh · conviction Medium
Quant / Technical

The Falling Knife

Beta near 3.5, a new 52-week low on Oct 22 on 2x normal volume, price below its 200-day average and a 36% fall from Sep 30. Trend is down; a base needs the Q3 print (~Nov 11) and a calmer bond tape.

12-MO TARGET $58 · 5.0× NTM EBITDA $20B − $66B net debt, ~585M sh · conviction Low
Macro / Sector strategist

The Cost of Money

Rates, not demand, are the repricing: Nvidia calls neocloud demand “off the charts” yet ~15% unsecured yields mean credit is the binding constraint. Goldman argues borrowing costs are overestimated; a calmer tape could re-rate the stub quickly.

12-MO TARGET $75 · 5.5× NTM EBITDA $20.5B − $66B net debt, ~625M sh · conviction Medium
03 · Wall Street’s read

Wall Street 12-month price targets

Selected sell-side targets, sorted low to high. The dashed line is today’s $54.24; the Street is split between a $39 Reduce and a $250 Street-high.

Consensus ≈ $130 (+140%) · 22 Buy / 5 Hold / 3 Sell · range $39–$250
BUYHOLDSELL
HSBC$39Bernstein$51MoffettNathanson$89Goldman Sachs$106BNP Paribas$117Evercore ISI$150Rosenblatt$250TODAY · $54.24

Targets as reported Oct 19–23, 2026: HSBC Reduce $39; Bernstein Underperform $51 (cut from $74 on Oct 22); MoffettNathanson Neutral $89; Goldman Sachs upgraded to Buy, $106 (from $139) on Oct 19; BNP Paribas Outperform $117; Evercore ISI Outperform $150; Rosenblatt Buy $250. Consensus sources differ: $129.90 (Benzinga), $134.84 (TipRanks), $136.21 (Yahoo), $140.58 (S&P Global, older). Firm ratings are the real sell-side calls; the analyst lenses above are not.

04 · Price scenarios — 1 / 2 / 3 / 5 years

Where the road leads

Synthesized scenario midpoints (mid-year), returns vs. today’s $54.24. Each price = NTM adjusted EBITDA × EV/EBITDA − net debt, divided by diluted shares. Illustrative frameworks, not predictions; a highly levered equity moves far more than the business does.

1 Year

Mid-2027
Bull$115+112%
Base$68+25%
Bear$39−28%
Prob-wtd$71+31%

2 Years

Mid-2028
Bull$179+230%
Base$83+53%
Bear$17−69%
Prob-wtd$87+61%

3 Years

Mid-2029
Bull$267+392%
Base$116+114%
Bear$20−63%
Prob-wtd$125+130%

5 Years

Mid-2031
Bull$344+534%
Base$144+165%
Bear$26−52%
Prob-wtd$159+192%
▸ Bull case — show the assumptions & math
Credit normalizes, backlog converts on schedule and pricing holds. NTM adjusted EBITDA rises from ~$23B (mid-2027) to ~$58B (mid-2031); multiple 6.0–6.5×; net debt $68B→$105B; diluted shares 610M→790M. The equity is levered, so a modest EV change swings the price a lot.
mid-2031: $58B NTM adj. EBITDA × 6.5× = $377B EV − $105B net debt = $272B ÷ 790M sh ≈ $344
▸ Base case — show the assumptions & math
Backlog converts roughly on consensus but ~10% late and costlier; NTM adjusted EBITDA ~$20B→$46B (below consensus 2028 path); multiple 5.0–5.5× (about today’s forward multiple); funding gap is closed with a mix of debt and ~35% more shares by 2031.
mid-2031: $46B NTM adj. EBITDA × 5.0× = $230B EV − $108B net debt = $122B ÷ 850M sh ≈ $144
▸ Bear case — show the assumptions & math
Funding costs stay near 15%, builds slip, and a second large equity raise is needed: NTM adjusted EBITDA only $19B→$30B, multiple 4.0–4.5×, net debt $62B→$95B and shares 600M→950M. Trough is mid-2028 at the refinancing wall.
mid-2031: $30B NTM adj. EBITDA × 4.0× = $120B EV − $95B net debt = $25B ÷ 950M sh ≈ $26
05 · Follow the cash

Revenue, capex, free cash flow & net debt ($B)

Where the money actually goes. The gap between the sky bar and the clay bar — and the olive bar below zero — is the whole funding debate.

Annual revenue, capex, FCF & net debt · 2023 → TTM Jun ’26
REVENUECAPEXFREE CASH FLOWNET DEBT
$50$40$30$20$10$0−$10202320242025TTM Jun ’260.22.9−1.11.81.98.7−6.09.35.110.3−7.326.77.620.6−13.746.0

Cash-flow capex ($2.9B → $8.7B → $10.3B → $20.6B TTM) outruns operating cash flow each year, so free cash flow (olive, drawn below zero) widens to −$13.7B TTM; net debt including leases (slate) reaches ~$46B. Management’s Q2 capex of $9.4B is accrual-based vs. $6.42B in the cash-flow statement, and the 2026 guide is $35–39B. Sources: StockAnalysis / company filings; TTM revenue $7.59B.

Energized vs. funded — the funding-gap gauge

Backlog is only revenue once capacity is built. Bars are scaled to Bernstein’s ~$85B need; estimates use different assumptions and are not like-for-like.

Bernstein · $85B need
$9B facilities$76B outside capital
Goldman · ~$19.5–23B new debt (after prepayments)
06 · Earnings power

Adjusted EBITDA path underpinning the targets ($B)

CoreWeave has no positive GAAP EPS to capitalize, so the targets are built on this adjusted EBITDA ladder times an exit multiple, less net debt.

Adjusted EBITDA · reported vs. estimated, 2024 → 2031E
REPORTEDCONSENSUSDESK EXTENSION
$0B$12B$24B$36B$48B202420252026E2027E2028E2029E2030E2031E$1.22B$3.09B$7.57B$16.63B$28.68B$36B$41B$46B

Gray = reported ($1.22B 2024, $3.09B 2025). Olive = consensus ($7.57B 2026E, $16.63B 2027E, $28.68B 2028E per MarketScreener; Motley Fool cites $7.6B and $16.7B). Faded olive = desk extension for 2029–31E, consistent with the base case. Consensus EPS is negative through 2027 (about −$4.33 for 2027, down from −$3.37 90 days earlier), so an EPS ladder would not underpin a price.

07 · Growth scorecard

Demand is growing — so are the costs

Q2 FY26, year-over-year. Read these against a stock at its 52-week low: the top line is intact, but interest and capex grow as fast or faster.

Year-over-year growth by metric · Q2 FY26
COREFRONTIERCOST
Adj. EBITDA (Q2)+100%Revenue (Q2)+112%Net interest expense+140%Q3 revenue guide (mid)+158%Cash capex (Q2)+162%Revenue backlog+246%

Adj. EBITDA $1.51B vs $753M; revenue $2.575B vs $1.212B; net interest $640M vs $267M; Q3 revenue guide $3.45–3.6B vs $1.365B (+158% at midpoint); cash capex $6.42B (+162% YoY); backlog $104B (+246%), excluding >$25B added in early Q3. Costs (terracotta) compounding with revenue is the bear’s point; backlog and guidance (clay) are the bull’s.

08 · The debate

Bull vs. Bear

The valuation argument compresses into one disagreement: is the backlog a financeable annuity, or a promise that must be funded at distress-level rates?

▲ THE BULL CASE

  • Backlog keeps growing. $104B at June 30 (+246%) with >$25B more committed in early Q3; Q3 revenue guided to $3.45–3.6B.
  • Pricing power. Compute prices raised 25% in July and 10% in October, per Goldman; Jensen Huang calls neocloud demand “off the charts.”
  • Operating leverage appears. Adj. operating income $128M vs $21M in Q1; operating cash flow +$679M vs −$251M a year ago.
  • Credit still open. Q2 interest landed at the low end of guidance; unsecured debt can still be placed, and NVIDIA invested $2B.
  • Cheap on contracts. ~$75B EV is ~4.5× 2027E consensus adjusted EBITDA and ~2.9× 2027E sales.
  • Crowded short. Short interest is 23.7% of float; a financing headline can reverse the tape fast.

▼ THE BEAR CASE

  • Funding gap. Bernstein: ~$85B needed, ~$76B outside capital; Goldman’s lower $23B is still large against a ~$30B market cap.
  • Cost of capital. The 2032 notes yield ~14.8% vs a 9.625% coupon; HSBC sees 2026–30E returns of 8.9%, below borrowing cost.
  • Cash burn. TTM free cash flow −$13.7B, FY26 capex $35–39B vs revenue $12.4–13.2B, net debt ~$46B.
  • Concentration. Microsoft was ~67% of FY25 revenue; backlog growth ex-OpenAI was 25%.
  • Structural disadvantage. HSBC: ~$12M revenue per MW in 2027 vs $17–18M for hyperscalers.
  • Losses and dilution. Q2 net loss $626M; consensus 2027 EPS slid to about −$4.33; equity may fund part of the gap.
09 · Risk map

Risk map — likelihood × impact

Over a 3–5 year horizon. The hot corner — likely and high-impact — is financing cost; the serious tail risks sit one row down.

Low impact
Medium impact
High impact
Likely
  • Depreciation drag
  • Equity dilution
  • Concentration
  • Financing cost
Possible
  • Power delays
  • GPU obsolescence
  • Credit shutoff
  • Counterparty default
Tail
  • Demand air-pocket

Financing cost

Likely × High

Unsecured paper trades near 15% against a 9.625% coupon; HSBC puts 2026–30E returns (8.9%) below the cost of borrowing — growth stops creating value.

Credit shutoff

Possible × High

The refinancing window closes before the $35–39B 2026 capex plan is funded; builds stall and backlog converts late.

Counterparty default

Possible × High

A large AI-lab customer cannot pay: Microsoft was ~67% of FY25 revenue and OpenAI is a major backlog name.

Equity dilution

Likely × Medium

Bernstein sees ~$76B of outside capital needed; any equity share of it dilutes holders at depressed prices.

Concentration

Likely × Medium

A handful of hyperscaler and AI-lab contracts drive the backlog; one renegotiation moves the whole model.

Demand air-pocket

Tail × High

LLM revenue growth moderates, GPU rental prices roll over and take-or-pay terms get tested — low odds, but the stub equity reprices fast.

Power delays

Possible × Medium

Active power lags contracted power; late energization delays revenue while interest keeps accruing.

GPU obsolescence

Possible × Medium

Faster NVIDIA cycles shorten useful life, raising depreciation and lowering residual value versus five-year contracts.

Depreciation drag

Likely × Low

GAAP losses persist (Q2 net loss $626M) even as adjusted EBITDA margins run near 59%.

10 · Plain-language glossary

The jargon, decoded

Hover the dotted terms in the metrics, or scan the desk’s working definitions here.

Revenue backlog
Contracted future revenue not yet recognized. It measures demand, not cash in hand; it converts only as capacity is delivered.
Take-or-pay
Contracts where the customer pays for reserved capacity whether or not it uses it — the basis for lenders financing CoreWeave builds.
Adjusted EBITDA
Earnings before interest, tax, depreciation, stock comp and one-offs. For CoreWeave it is ~59% of revenue but excludes the GPU depreciation and interest that drive GAAP losses.
Net debt (incl. leases)
Debt plus lease obligations minus cash — ~$46B at June 30, 2026 (StockAnalysis). It is the subtraction between enterprise value and equity value.
Funding gap
Outside capital needed to build what is already contracted. Bernstein: ~$76B after ~$9B of facilities; Goldman: ~$19.5–23B including prepayments.
EV / EBITDA
Enterprise value divided by EBITDA. Targets here are NTM EBITDA × an exit multiple − net debt, divided by shares — the stub equity is highly sensitive.
Neocloud
A specialist GPU-rental cloud (CoreWeave, Nebius, IREN) competing with hyperscalers on speed to capacity rather than breadth of services.
Prob-weighted
Each scenario price times its probability, summed into one expected value across bear, base and bull.
NOT FINANCIAL ADVICE

Sources & method (as of Oct 23, 2026 close): Price $54.24 (Finviz, Oct 23 close; CNBC Oct 22 close $55.60, 52-wk low $53.50 Oct 22, high $141.79 Oct 28, 2025); shares ~551.5M, market cap ~$29.9B (sources show $29.9–34.1B); EV ~$75B (Finviz $75.1B; Motley Fool $76.2B). CoreWeave Q2 2026 release (Aug 11, 2026), FY2025 annual report, CNBC, Benzinga, TipRanks, Bernstein/Goldman/HSBC notes via press reports (Oct 15–23), StockAnalysis and BusinessQuant cash-flow data, MarketScreener estimates, Motley Fool consensus. Conflicts: active/contracted power is reported as 1.5 GW (CNBC) to 1.85 GW (Motley Fool) vs 3.7–4.2 GW contracted; Q2 capex is $9.4B accrual vs $6.42B cash; 2032 notes yield ~14.8%. Multiples are derived. Next earnings ~Nov 11 (Yahoo; unconfirmed by the company). The six “analyst lenses” are synthesized frameworks — not real people or real firm ratings. Scenario prices are illustrative midpoints, not forecasts; actual outcomes can fall outside the cone. Not financial advice — do your own research and consider consulting a licensed financial advisor.